ALV 317 (Nevirapine extended release 400 mg)
This pill with imprint "ALV 317" is White, Capsule-shape and has been identified as Nevirapine extended release 400 mg. It is supplied by Alvogen Inc..
Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
Nevirapine extended release
- Imprint:
- ALV 317
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- NNRTIs
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Alvogen Inc.
- National Drug Code (NDC):
- 47781-0317
More about nevirapine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: NNRTIs
Consumer resources
- Nevirapine Extended-Release Tablets
- Nevirapine Oral Suspension
- Nevirapine Tablets
- Nevirapine
- Nevirapine (Advanced Reading)
Other brands: Viramune, Viramune XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
